Dose: 4.5 mg/kg
Single Dose: 4.5 (4.5)
Frequency: As recommended.
Route: IM
Instructions:

. The Molecular Weight of Sissomicin Sulphate is 1385.40.

Sissomicin Sulphate is contraindicated in conditions like Hypersensitivity.

The severe or irreversible adverse effects of Sissomicin Sulphate, which give rise to further complications include Convulsions, Muscular weakness, Respiratory depression.The signs and symptoms that are produced after the acute overdosage of Sissomicin Sulphate include Confusion, Nephrotoxicity.The symptomatic adverse reactions produced by Sissomicin Sulphate are more or less tolerable and if they become severe, they can be treated symptomatically, these include Ototoxicity, Nausea and vomiting, Hypokalemia, Purpura, Hypocalcemia.

Sissomicin Sulphate is primarily indicated in conditions like Biliary tract infections, Brucellosis, Endocarditis, and can also be given in adjunctive therapy as an alternative drug of choice in Cystic fibrosis, Endometriosis, Skin infections, Urinary tract infection.

No data regarding the interactions of Sissomicin Sulphate was found.

Drug should not be given to patients suffering from Kidney dysfunction.If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

Inj Store in a well closed container, . Protect from Sunlight, Moisture and Heat.

It should be avoided in patients with Myesthenia gravis. Great care is required in patients of Parkinsonism.